Strata Skin Sciences (SSKN) Stock Price, News & Analysis

Company Overview

Strata Skin Sciences, Inc. is a medical technology company headquartered in Edison, New Jersey, that specializes in developing and commercializing dermatological devices and therapies. The company’s flagship offering is the XTRAC® excimer laser system, an FDA‐cleared, 308-nanometer ultraviolet light device used to treat skin conditions such as vitiligo and psoriasis. Strata’s product suite also includes associated accessories and disposables, as well as clinical services and training programs designed to support dermatology practices and improve patient outcomes.

Strata Skin Sciences expanded its portfolio and market presence through the strategic acquisition of PhotoMedex in 2019, bringing together complementary phototherapy and energy-based technologies under one roof. This integration enabled the company to widen its geographic footprint, serving physicians and clinics across the United States and through select international distribution partners in Europe and Asia. Strata continues to invest in clinical research, product enhancements and next-generation platforms aimed at addressing a range of dermatologic disorders with noninvasive treatment modalities.

Under the leadership of Chairman and Chief Executive Officer David J. Peskin, Strata Skin Sciences maintains a direct sales force of clinical specialists who provide installation, training and ongoing support for its laser and light‐based systems. The company’s operational strategy focuses on fostering long-term partnerships with dermatology practices, promoting the adoption of its technologies through peer-reviewed publications, educational initiatives and real-world evidence studies. As a result, Strata has positioned itself as a focused provider of advanced phototherapy solutions within the skin disease market.

Key Stats

• Today's Range: $0.13 to $0.18
• 50-Day Range: $0.12 to $0.29
• 52-Week Range: $0.11 to $3.86
• Volume: 15,401 shs
• Average Volume: 312,722 shs
• Market Capitalization: $765.44 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

SSKN Stock Analysis - Frequently Asked Questions

How have SSKN shares performed this year?

Strata Skin Sciences' stock was trading at $1.26 on January 1st, 2026. Since then, SSKN stock has decreased by 89.7% and is now trading at $0.13.

How were Strata Skin Sciences' earnings last quarter?

Strata Skin Sciences, Inc. (NASDAQ:SSKN) posted its quarterly earnings data on Thursday, November, 13th. The medical device company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.12. The medical device company had revenue of $6.93 million for the quarter, compared to the consensus estimate of $7.72 million. Strata Skin Sciences had a negative trailing twelve-month return on equity of 476.73% and a negative net margin of 35.64%.
Read the conference call transcript.

When did Strata Skin Sciences' stock split?

Strata Skin Sciences shares reverse split on Friday, June 7th 2024.The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Strata Skin Sciences?

Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Strata Skin Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Strata Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM).

Company Calendar

• Last Earnings: 11/13/2025
• Today: 5/07/2026
• Next Earnings (Estimated): 5/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SSKN
• CIK: 1051514
• Web: www.strataskinsciences.com
• Phone: (215) 619-3200
• Fax: 215-619-3208
• Employees: 120
• Year Founded: 1989

Profitability

• EPS (Trailing Twelve Months): ($1.41)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.09 million
• Net Margins: -35.64%
• Pretax Margin: -36.34%
• Return on Equity: -476.73%
• Return on Assets: -33.49%

Debt

• Debt-to-Equity Ratio: 10.22
• Current Ratio: 0.95
• Quick Ratio: 0.75

Sales & Book Value

• Annual Sales: $30.98 million
• Price / Sales: 0.02
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.19 per share
• Price / Book: 0.11

Miscellaneous

• Outstanding Shares: 5,888,000
• Free Float: 3,479,000
• Market Cap: $765.44 thousand
• Optionable: Not Optionable
• Beta: -0.05